What's Happening?
NASA's Translational Research Institute for Space Health (TRISH) is inviting proposals to study venous thromboembolism (VTE) in space. VTE, which involves the formation of blood clots in veins, poses a significant health risk during spaceflight. The mechanisms
behind VTE in microgravity are not fully understood, and current preventive measures are limited. TRISH aims to advance understanding of VTE pathophysiology in space and develop ground-based analogs to replicate these conditions. The initiative seeks innovative research proposals from U.S. institutions and companies, with funding available up to $500,000 for projects lasting up to 15 months.
Why It's Important?
Understanding and mitigating the risk of VTE is critical for the safety of astronauts on long-duration missions. Blood clots can lead to serious complications, such as pulmonary embolism, which could be life-threatening in space. By addressing this health risk, NASA aims to ensure the well-being of astronauts and the success of future exploration missions. The research could also have broader implications for medical science, potentially leading to new insights and treatments for blood clotting disorders on Earth.
What's Next?
Interested researchers must submit their proposals by August 18, 2026. Selected projects will contribute to closing knowledge gaps and developing practical solutions for space health challenges. The outcomes of this research will be crucial for planning future missions, particularly those involving extended stays in space, such as missions to Mars. The findings may also influence medical practices and technologies used in terrestrial healthcare settings.
